Changes in Cardiac Function and Exercise Capacity Following Ferric Carboxymaltose Administration in HFrEF Patients with Iron Deficiency

<b>Background/Objectives:</b> Iron deficiency (ID) is a common and prognostically relevant comorbidity in heart failure with reduced ejection fraction (HFrEF). It contributes to reduced functional status, exercise capacity, and survival. Intravenous ferric carboxymaltose (FCM) improves symptoms, but...

Description complète

Détails bibliographiques

Auteurs principaux:	Anastasios Tsarouchas, Constantinos Bakogiannis, Dimitrios Mouselimis, Christodoulos E. Papadopoulos, Efstratios K. Theofillogiannakos, Efstathios D. Pagourelias, Ioannis Kelemanis, Aristi. Boulmpou, Antonios P. Antoniadis, Nikolaos Fragakis, Georgios Efthimiadis, Theodoros D. Karamitsos, Vassilios P. Vassilikos
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2025-08-01
Collection:	Diagnostics
Sujets:	HFrEF ferric carboxymaltose strain imaging iron deficiency exercise capacity diastolic dysfunction
Accès en ligne:	https://www.mdpi.com/2075-4418/15/15/1941
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!